Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Result of Surgical Treatment of Stage IIIB Lung Cancer

제3D 병기 폐암의 수술성적

  • 홍기표 (연세대학교 의과대학 흉부외과학교실)
  • Published : 2000.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Though the surgical treatment of stage IIIB lung cancer is not generalized due to low complete remission rate high morbidity and mortality there are several reports on the improvement of long term survival after preoperative and postoperative adjuvant therapy. In this study we analyzed the prognostic factors affecting long term survival after surgical treatment of stage IIIB lung cancer Material and method: We analyzed the long term survival for age pathology invaded mediastinal organ n stage type of operation complete or incomplete resection and adjuvant therapy through a retrospective review of patients underwent surgical treatment. Result: From 1990 to 1998 56 patients(51/male 5/female0 with stage IIIB lung cancer were trated surgically. Forty two patients underwent radical resection and morbidity and mortality were 17% 12% respectively. The survival rate for overall patients and the radical resection group were 9% 12% respectively. In the radical resection group excluding explothoracotomy only(n=14) and the surgical mortality patients(n=5) the age the type of operation celly type resectability and N stage had no influence on the long term survival. The survival rate of radical resection group was significantly better than that of the explothoracotomy only group(p=0.04) The long term survival rate of postoperative combination therapy group was significantly better than chemotherapy or radiotherapy alone(p=0.04) Conclsion: Age type after surgical treatment of stage IIIB lung cancer. We conclude that combined modality of adjuvant treatment after radical resection of stage IIIB lung cancer seems to offer better long term survival in selective patients. The numbers of patients involved was small. Nevertheless these preliminary findings indicate questions that will need to be experienced further in larger studies.

Keywords

References

  1. J Thorac Cardiovasc Surg v.83 Bronchogenic carcinoma located in the aortic window Levett JM.;Darakjian HE.;DeMeester TR.;et al.
  2. J Thorac Cardiovasc Surg v.97 Extended operation for lung cancer invading the aortic arch and superior vena cava Nakajara K.;Ohno K.;Matsumura A.;et al.
  3. Ann Thorac Surg v.57 Extended resection of the left atrium great vessels or both for lung cancer Tsuchiya R.;Asamura H.;Kondo H.;Goya T.;Naurke T.
  4. J Thorac Cardiovasc Surg v.110 Risk analysis and longtern survival in patients undergoing extenede resection of locally advanced lung cancer Izbicki JR.;Konefel WT.;Passlick B.;Habekost M.;Karg O.;Thetter O.
  5. J Surg Oncol v.47 Results of treatment and lessons learned from pathologically staged T4 Non-small cell lung cancer Macchiarini P.;Silvano G.;Janni A.;Mussi A.;Chella A.;Angeletti CA.
  6. Eur J Cardiovasc Surg v.11 Extended operation for non-small cell lung cancer invading great vessels and left atrium Fukuse T.;Wada H.;Hitomi S.
  7. Surg Clin North Am v.67 Results of surgical treatement of stageⅢ lung cancer invading the mediastinum Burt ME.;Pomerantz AH.;Bains MS.
  8. Ann Thorac Surg v.58 Management of non-small cell lung cancer with direct mediastinal involvement Martini N.;Yellin A.;Ginsberg RJ.;et al.
  9. J Thorac Cardiovasc Surg v.96 Prognosis and survival in resected lung carcinoma based on the new international staging system Naurke T.;Goya T.;Tsuchiya R.;Suemasu K.
  10. 대흉외지 v.30 원발성 비소세포성 폐암의 외과적 치료 최준영;김병균;장인석 등
  11. 대흉외지 v.30 비소세포성 폐암의 외과적 치료에 대한 성적 박진규;조중구;김공수
  12. 대흉외지 v.31 원발성 폐암의 외과적 치료 김성완;구본원;이응배;전상훈;장봉현
  13. Ann Thorac Surg v.50 Resection of superior vena cava for primary lung cancers;5year' survival Inoue H.;Shohtsu A.;Koide S.;Ogawa J.
  14. J Clin Oncol v.6 for the Lung Cancer Study Group The benefit of adjuvant treatment for resected locally advanced non-small cell lung cancer Lad T.;Rubinstein L.;Sadegehi A.